Naloxone hydrochloride dihydrate,
51481-60-8,
Naloxone HCl Dihydrate,
Naloxone chlorhydrate,
UNII-5Q187997EE,
5Q187997EE,
(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;dihydrate;hydrochloride,
C19H26ClNO6,
C19H21NO4.ClH.2H2O,
DTXSID90199452,
2576AH,
MFCD00150901,
s4501,
Naloxone Hydrochloride, Dihydrate USP,
AKOS030488390,
AN-12940,
Q-201445,
Naloxone hydrochloride dihydrate, >=98% (TLC and titration), powder,
Naloxone, Pharmaceutical Secondary Standard; Certified Reference Material,
4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one hydrochloride dihydrate,
Naloxone for peak identification, European Pharmacopoeia (EP) Reference Standard,
Naloxone Hydrochloride Dihydrate 1.0 mg/ml in Methanol (as anhydrous free base),
Naloxone hydrochloride dihydrate, European Pharmacopoeia (EP) Reference Standard,
(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one hydrochloride dihydrate,
Naloxonehydrochloridedihydrate,
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, hydrochloride, dihydrate, (5.alpha.)-,